Page last updated: 2024-10-25

clenbuterol and Subarachnoid Hemorrhage

clenbuterol has been researched along with Subarachnoid Hemorrhage in 1 studies

Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.

Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.

Research Excerpts

ExcerptRelevanceReference
"To investigate the possible therapeutic effects of clenbuterol on cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats."7.77The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. ( Acar, F; Benek, B; Cirak, B; Coskun, E; Ozcakar, L; Suzer, T; Tahta, K; Yalcin, N, 2011)
"To investigate the possible therapeutic effects of clenbuterol on cerebral vasospasm after subarachnoid hemorrhage (SAH) in rats."3.77The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. ( Acar, F; Benek, B; Cirak, B; Coskun, E; Ozcakar, L; Suzer, T; Tahta, K; Yalcin, N, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benek, B1
Acar, F1
Cirak, B1
Coskun, E1
Ozcakar, L1
Yalcin, N1
Suzer, T1
Tahta, K1

Other Studies

1 other study available for clenbuterol and Subarachnoid Hemorrhage

ArticleYear
The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.
    Acta neurologica Belgica, 2011, Volume: 111, Issue:3

    Topics: Adrenergic beta-Agonists; Animals; Basilar Artery; Cerebrovascular Circulation; Clenbuterol; Disease

2011